![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 2
2019
Reiter, Florian P.; Denk, Gerald; Ziesch, Andreas; Ofner, Andrea; Wimmer, Ralf; Hohenester, Simon; Schiergens, Tobias S.; Spampatti, Matilde; Ye, Liangtao; Itzel, Timo; Munker, Stefan; Teufel, Andreas; Gerbes, Alexander L.; Mayerle, Julia und De Toni, Enrico N.
(2019):
Predictors of ribociclib-mediated antitumour effects in native and sorafenib-resistant human hepatocellular carcinoma cells.
In: Cellular Oncology, Bd. 42, Nr. 5: S. 705-715
2016
Reuther, Clemens; Heinzle, Vera; Spampatti, Matilde; Vlotides, George; De Toni, Enrico; Spöttl, Gerald; Maurer, Julian; Nölting, Svenja; Göke, Burkhard und Auernhammer, Christoph J.
(2016):
Cabozantinib and Tivantinib, but Not INC280, Induce Antiproliferative and Antimigratory Effects in Human Neuroendocrine Tumor Cells in vitro: Evidence for 'Off-Target' Effects Not Mediated by c-Met Inhibition.
In: Neuroendocrinology, Bd. 103, Nr. 3-4: S. 383-401
[PDF, 916kB]